Literature DB >> 16254141

AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation.

Saghi Ghaffari1, Claire Kitidis, Wei Zhao, Dragan Marinkovic, Mark D Fleming, Biao Luo, Joseph Marszalek, Harvey F Lodish.   

Abstract

AKT serine threonine kinase of the protein kinase B (PKB) family plays essential roles in cell survival, growth, metabolism, and differentiation. In the erythroid system, AKT is known to be rapidly phosphorylated and activated in response to erythropoietin (Epo) engagement of Epo receptor (EpoR) and to sustain survival signals in cultured erythroid cells. Here we demonstrate that activated AKT complements EpoR signaling and supports erythroid-cell differentiation in wild-type and JAK2-deficient fetal liver cells. We show that erythroid maturation of AKT-transduced cells is not solely dependent on AKT-induced cell survival or proliferation signals, suggesting that AKT transduces also a differentiation-specific signal downstream of EpoR in erythroid cells. Down-regulation of expression of AKT kinase by RNA interference, or AKT activity by expression of dominant negative forms, inhibits significantly fetal liver-derived erythroid-cell colony formation and gene expression, demonstrating that AKT is required for Epo regulation of erythroid-cell maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254141      PMCID: PMC1895702          DOI: 10.1182/blood-2005-06-2304

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Authors:  Wei Zhao; Claire Kitidis; Mark D Fleming; Harvey F Lodish; Saghi Ghaffari
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway.

Authors:  M K Henry; J T Lynch; A K Eapen; F W Quelle
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

4.  Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.

Authors:  Y Kubota; T Tanaka; A Kitanaka; H Ohnishi; Y Okutani; M Waki; T Ishida; H Kamano
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors.

Authors:  S Ghaffari; C Kitidis; M D Fleming; H Neubauer; K Pfeffer; H F Lodish
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

7.  BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells.

Authors:  S Ghaffari; H Wu; M Gerlach; Y Han; H F Lodish; G Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage.

Authors:  T Kina; K Ikuta; E Takayama; K Wada; A S Majumdar; I L Weissman; Y Katsura
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

9.  A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction.

Authors:  Y Kashii; M Uchida; K Kirito; M Tanaka; K Nishijima; M Toshima; T Ando; K Koizumi; T Endoh; K Sawada; M Momoi; Y Miura; K Ozawa; N Komatsu
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

10.  Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.

Authors:  S Uddin; S Kottegoda; D Stigger; L C Platanias; A Wickrema
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

View more
  35 in total

Review 1.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

2.  Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression.

Authors:  Stuart T Fraser; Joan Isern; Margaret H Baron
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

3.  Erythropoiesis lagging? pIgA1 steps in to assist Epo.

Authors:  Robert F Paulson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

4.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis.

Authors:  Dragan Marinkovic; Xin Zhang; Safak Yalcin; Julia P Luciano; Carlo Brugnara; Tara Huber; Saghi Ghaffari
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 5.  Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.

Authors:  Stefano Rivella
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

6.  Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Authors:  Ilaria V Libani; Ella C Guy; Luca Melchiori; Raffaella Schiro; Pedro Ramos; Laura Breda; Thomas Scholzen; Amy Chadburn; YiFang Liu; Margrit Kernbach; Bettina Baron-Lühr; Matteo Porotto; Maria de Sousa; Eliezer A Rachmilewitz; John D Hood; M Domenica Cappellini; Patricia J Giardina; Robert W Grady; Johannes Gerdes; Stefano Rivella
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

7.  Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Authors:  Wei Zhao; Claire Kitidis; Mark D Fleming; Harvey F Lodish; Saghi Ghaffari
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

8.  Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α.

Authors:  Kira Gritsman; Haluk Yuzugullu; Thanh Von; Howard Yan; Linda Clayton; Christine Fritsch; Sauveur-Michel Maira; Gregory Hollingworth; Christine Choi; Tulasi Khandan; Mahnaz Paktinat; Rachel O Okabe; Thomas M Roberts; Jean J Zhao
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

9.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

10.  beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload.

Authors:  Luca Melchiori; Sara Gardenghi; Stefano Rivella
Journal:  Adv Hematol       Date:  2010-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.